These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Does primary sclerosing cholangitis occurring in association with inflammatory bowel disease differ from that occurring in the absence of inflammatory bowel disease? A study of sixty-six subjects. Rabinovitz M; Gavaler JS; Schade RR; Dindzans VJ; Chien MC; Van Thiel DH Hepatology; 1990 Jan; 11(1):7-11. PubMed ID: 2295474 [TBL] [Abstract][Full Text] [Related]
17. The challenges in primary sclerosing cholangitis--aetiopathogenesis, autoimmunity, management and malignancy. Weismüller TJ; Wedemeyer J; Kubicka S; Strassburg CP; Manns MP J Hepatol; 2008; 48 Suppl 1():S38-57. PubMed ID: 18304683 [TBL] [Abstract][Full Text] [Related]
18. Management of primary sclerosing cholangitis and its complications: an algorithmic approach. Prokopič M; Beuers U Hepatol Int; 2021 Feb; 15(1):6-20. PubMed ID: 33377990 [TBL] [Abstract][Full Text] [Related]
19. Advances in primary sclerosing cholangitis. Lindor KD; Wiesner RH; MacCarty RL; Ludwig J; LaRusso NF Am J Med; 1990 Jul; 89(1):73-80. PubMed ID: 2195892 [TBL] [Abstract][Full Text] [Related]